SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Meyers PA, Gorlick R, Heller G, et al. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol. 1998; 16: 24522458.
  • 2
    Meyer WH, Pratt CB, Poquette CA, et al. Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. J Clin Oncol. 2001; 19: 171182.
  • 3
    Provisor AJ, Ettinger LJ, Nachman JB, et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol. 1997; 15: 7684.
  • 4
    Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group Protocols. J Clin Oncol. 2002; 20: 776790.
  • 5
    Bacci G, Ferrari S, Longhi A, et al. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Eur J Cancer. 2001; 37: 3238.
  • 6
    Neel M, Toy P, Daw NC, et al. Endoprosthetic survival following reconstruction in the skeletally immature patient (SIP) [abstract]. Med Pediatr Oncol. 2001; 37: 342.
  • 7
    Daw NC, Mahmoud HH, Meyer WH, et al. Bone sarcomas of the head and neck in children: the St. Jude Children's Research Hospital experience. Cancer. 2000; 88: 21722180.
  • 8
    Weeden S, Grimer RJ, Cannon SR, Taminiau AHM, Uscinska BM. The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer. 2001; 37: 3946.
  • 9
    Bacci G, Ferrari S, Mercuri M, et al. Predictive factors for local recurrence in osteosarcoma. 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand. 1998; 69: 230236.
  • 10
    Ferrari S, Bacci G, Picci P, et al. Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol. 1997; 8: 765771.
  • 11
    Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the Istituto Ortopedico Rizzoli according to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 protocol: an updated report. J Clin Oncol. 2000; 18: 40164027.
  • 12
    Goorin AM, Shuster JJ, Baker A, Horowitz ME, Meyer WH, Link MP. Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the Multiinstitutional Osteosarcoma Study. J Clin Oncol. 1991; 9: 600605.
  • 13
    Saeter G, Hoie J, Stenwig AE, Johansson AK, Hannisdal E, Solheim ØP. Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival. Cancer. 1995; 75: 10841093.
  • 14
    Tabone M-D, Kalifa C, Rodary C, Raquin M, Valteau-Couanet D, Lemerle J. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. J Clin Oncol. 1994; 12: 26142620.
  • 15
    Fuchs N, Bielack SS, Epler D, et al. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998; 9: 893899.
  • 16
    Picci P, Sangiorgi L, Rougraff BT, et al. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol. 1994; 12: 26992705.
  • 17
    Brosjö, O. Surgical procedure and local recurrence in 223 patients treated 1982-1997 according to two osteosarcoma chemotherapy protocols. Acta Orthop Scand. 1999; 70 (Suppl 285): 5861.
  • 18
    Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457481.
  • 19
    Peto P, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977; 35: 139.
  • 20
    Pratt CB, Champion JE, Fleming ID, et al. Adjuvant chemotherapy for osteosarcoma of the extremity: long-term results of two consecutive prospective protocol studies. Cancer. 1990; 65: 439445.
  • 21
    Tabone M-D, Terrier Ph, Pacquement H, et al. Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases. J Clin Oncol. 1999; 17: 27892795.
  • 22
    Jaffe N, Knapp J, Chuang VP, et al. Osteosarcoma: intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Cancer. 1983; 51: 402407.
  • 23
    Winkler K, Bielak S, Delling G, et al. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Cancer. 1990; 66: 17031710.
  • 24
    Bacci G, Ferrari S, Tienghi A, et al. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity. Eur J Surg Oncol. 2001; 27: 98104.
  • 25
    Rodriguez-Galindo C, Billups CA, Kun LE, et al. Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital Experience, 1979-1999. Cancer. 2002; 94: 561569.
  • 26
    Reddick WE, Wang S, Xiong X, et al. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer. 2001; 91: 22302237.
  • 27
    Ozonoff MB. Skeletal trauma. In: Ozonoff, MB, editor. Pediatric orthopedic radiology. 2nd edition. Philadelphia: W.B. Saunders, Inc., 1992: 604689.
  • 28
    Greenfield GB. Soft tissues. In: GreenfieldGB, editor. Radiology of bone diseases. 5th edition. Philadelphia: J.B. Lippincott, Inc., 1990: 733801.
  • 29
    Kaste SC, Neel MN, Rao BN, Thompson VF, Pratt CB. Complications of limb-sparing procedures using endoprosthetic replacements about the knee for pediatric skeletal sarcomas. Pediatr Radiol. 2001; 31: 6271.
  • 30
    Viano AM, Gronemeyer SA, Haliloglu M, Hoffer FA. Improved MR imaging for patients with metallic implants. Magn Reson Imaging 2000; 18: 287295.
  • 31
    Caluser CI, Abdel-Dayem HM, Macapinlac HA, et al. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med. 1994; 21: 11981205.
  • 32
    Kostakoglu L, Panicek DM, Divgi CR, et al. Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas. Eur J Nucl Med. 1995; 22: 12321237.